Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
For instance, in August 2024, Eli Lilly and Company announced positive topline results from the SURMOUNT-1 trial, a three-year study evaluating the effectiveness and safety of tirzepatide (marketed as Zepbound and Mounjaro) administered once weekly for long-term weight management and delaying the progression to diabetes in adults with pre-diabetes and obesity or overweight
Mortimore 2010
Injection-site redness: Usually mild
Importantly, doctors advise anyone taking a GLP-1 medication for weight loss to also engage in wholesome, nutritious eating and exercise as part of a healthy and sustainable weight loss plan
The right choice depends on the patients needs and health
